Youji Harada

A multicenter study to clarify the optimal HCV-RNA negative period during combined therapy with pegylated interferon plus ribavirin in patients with chronic hepatitis caused by HCV genotype 2.

I. Nakamura, A. Saito, A. Matsui, 2012, Internal medicine.

Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL‐28B Gene Allele and Viral Response Trial (AG & RGT)

S. Mochida, M. Inao, S. Nagoshi, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.